Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion type Assertion NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_head.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion description "[The results showed a higher frequency of the ECRG2 TCA (3)/TCA (4) genotype in cancer patients than in controls (odds ratio 2.6, 95% CI 1.0-6.4, p = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_provenance.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion evidence source_evidence_literature NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_provenance.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion SIO_000772 18618216 NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_provenance.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion wasDerivedFrom befree-20140225 NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_provenance.
- NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_assertion wasGeneratedBy ECO_0000203 NP267993.RAshX0yUhscWbdA7peBiGBD4B45aZPtnIoaEkogHIqr7g130_provenance.